T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective study

Haematologica

Volumn 88, Issue 9, 2003, Pages 1079-1080

  Giordano, Paola ^a   Santoro, Nicola ^a   Del Vecchio, Giovanni Carlo ^a   Rizzari, Carmelo ^b   Masera, Giuseppe ^b   De Mattia, Domenico ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

ALL; Children; Thrombosis

Indexed keywords

ASPARAGINASE; BLOOD CLOTTING FACTOR 5 LEIDEN; MEDAC; PROTHROMBIN; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG SAFETY; FEMALE; HUMAN; IMMUNOPHENOTYPING; MALE; PREVALENCE; RISK FACTOR; T LYMPHOCYTE; THROMBOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL, ACUTE; MALE; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 0141478862     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mitchell L, Hoogendoorn H, Giles AR, Vegh P, Andrew M. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L-asparaginase induced antithrombin III deficiency. Blood 1994;83:386-91.
2. Nowak-Gottl U, Wermes C, Junker R, Koch H, Schobess R, Fleischhack G, et al. Prospective evaluation in the thrombotic risk in children with acute lymphoblastic leukaemia carrying the MTHFR TT677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999;98:1595-9.
3. Mauz Korholz C, Junker R, Gobel U, Nowak-Gottl U. Prothrombotic risk factors in children with acute lymphoblastic leukaemia treated with delayed E. Coli asparaginase (COALL-92 and 97 protocols). Thromb Haemost 2000;83:840-3.
4. Nowak-Gottl U, Ahlke E, Fleischhack G, Schwabe D, Schobess R, Schumann C, et al. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood 2003;101:2529-33.
5. Giordano P, Del Vecchio GC, Santoro N, Arcamone G, Coppola B, Altomare M, et al. Thrombin generation in children with acute lymphoblastic leukaemia: effect of leukaemia immunophenotypic subgroups. Pediatr Hematol Oncol 2000;17:667-72.
6. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and terapeutic implications. Haematologica 2002;87:1095-108.
7. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-31.
8. Barrowcuffe TW, Fabregas P, Cancelas J, Rabaneda M, Pickering W, Gray E, et al. Promotion of factor Xa and thrombin generation by T lymphoblastoid cell lines. Haemostasis 2001;31:72.
9. Dreyfus M. Thrombotic risk in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2001;18:233-4.
10. Zucchella M, Pacchiarini L, Meloni F, Ballabio P, Saporiti A, Brocchieri A, et al. Effect of interferon α, interferon γ and tumor necrosis factor on the procoagulant activity of human cancer cells. Haematologica 1993;78:2826.